Trial Profile
Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 04 Oct 2017 New trial record